PILLER Véronique

email : veronique.piller@cnrs-orleans.fr

Phone :+33 2.38.25.76.46 ou 78.05

Office A211

Researcher within the thematic group “Synthetic protein and bioorthogonal chemistry

 



18 documents

    2018

  • David Montoir, Mehdi Amoura, Zine El Abidine Ababsa, T. Vishwanatha, Expédite Yen-Pon, et al.. Synthesis of aryl-thioglycopeptides through chemoselective Pd-mediated conjugation. Chemical Science , The Royal Society of Chemistry, 2018, 9 (46), pp.8753-8759. ⟨hal-01966170⟩
  • 2017

  • Aline Mongis, Friedrich Piller, Véronique Piller. Coupling of Immunostimulants to Live Cells through Metabolic Glycoengineering and Bioorthogonal Click Chemistry. Bioconjugate Chemistry, American Chemical Society, 2017, 28 (4), pp.1151 - 1165. 〈10.1021/acs.bioconjchem.7b00042〉. 〈hal-01618670〉
  • 2015

  • Mathieu Galibert, Véronique Piller, Friedrich Piller, Vincent Aucagne, Agnès F. Delmas. Combining triazole ligation and enzymatic glycosylation on solid phase simplifies the synthesis of very long glycoprotein analogues. Chemical Science , The Royal Society of Chemistry, 2015, 6 (6), pp.3617-3623. ⟨10.1039/C5SC00773A⟩. ⟨hal-01178852⟩
  • 2014

  • Kelly N. Chuh, Balyn W. Zaro, Friedrich Piller, Véronique Piller, Matthew R. Pratt. Changes in Metabolic Chemical Reporter Structure Yield a Selective Probe of O-GlcNAc Modification. Journal of the American Chemical Society, American Chemical Society, 2014, 136 (35), pp.12283-12295. 〈10.1021/ja504063c〉. 〈hal-01178483〉
  • 2012

  • Sabrina Pouilly, Vanessa Bourgeaux, Friedrich Piller, Véronique Piller. Evaluation of analogues of GalNAc as substrates for enzymes of the mammalian GalNAc salvage pathway.. ACS Chemical Biology, American Chemical Society, 2012, 7 (4), pp.753-60. 〈10.1021/cb200511t〉. 〈hal-00726252〉
  • Sabrina Pouilly, Véronique Piller, Friedrich Piller. Metabolic glycoengineering through the mammalian GalNAc salvage pathway.. FEBS Journal, Wiley, 2012, 279 (4), pp.586-98. ⟨10.1111/j.1742-4658.2011.08448.x⟩. ⟨hal-00726255⟩
  • Alicja Solatycka, Tomasz Owczarek, Friedrich Piller, Véronique Piller, Bartosz Pula, et al.. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase. Glycobiology, Oxford University Press (OUP), 2012, 22 (8), pp.1042-54. ⟨10.1093/glycob/cws075⟩. ⟨hal-00726281⟩
  • 2007

  • Vanessa Bourgeaux, Martine Cadene, Friedrich Piller, Véronique Piller. Efficient enzymatic glycosylation of peptides and oligosaccharides from GalNAc and UTP. ChemBioChem, Wiley-VCH Verlag, 2007, 8 (1), pp.37-40. 〈hal-00282379〉
  • Vanessa Bourgeaux, Martine Cadène, Friedrich Piller, Véronique Piller. Efficient Enzymatic Glycosylation of Peptides and Oligosaccharides from GalNAc and UTP. ChemBioChem, Wiley-VCH Verlag, 2007, 8 (1), pp.37-40. 〈10.1002/cbic.200600369〉. 〈hal-00158348〉
  • 2006

  • Teresa Freire, Richard Lo-Man, Friedrich Piller, Véronique Piller, Claude Leclerc, et al.. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.. Glycobiology, Oxford University Press (OUP), 2006, 16 (5), pp.390-401. ⟨10.1093/glycob/cwj082⟩. ⟨pasteur-00166623⟩